World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders. Part 2: Maintenance Treatment of Major Depressive Disorder-Update 2015

References

• Aaronson ST, Carpenter LL, Conway CR, Reimherr FW, Lisanby SH, Schwartz TL, et al. 2013. Vagus nerve stimulation therapy randomized to different amounts of electrical charge for treatment-resistant depression: acute and chronic effects. Brain Stimul 6(4):631–640.
   PubMed Web of Science ®Google Scholar
• Agency for Health Care Policy and Research. 1993. Depression in primary care: detection, diagnosis, and treatment. Agency for Health Care Policy and Research. Clin Pract Guidel Quick Ref Guide Clin (5):1–20.
   Google Scholar
• Akiskal HS, Maser JD, Zeller PJ, Endicott J, Coryell W, Keller M, et al. 1995. Switching from “unipolar” to bipolar II. An 11-year prospective study of clinical and temperamental predictors in 559 patients. Arch Gen Psychiatry 52(2):114–123.
   PubMed Web of Science ®Google Scholar
• Altshuler LL, Post RM, Leverich GS, Mikalauskas K, Rosoff A, Ackerman L. 1995. Antidepressant-induced mania and cycle acceleration: a controversy revisited. Am J Psychiatry 152(8):1130–1138.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. 1994. Practice guideline for the treatment of patients with bipolar disorder. American Psychiatric Association. Am J Psychiatry 151(12 Suppl):1–36.
   Web of Science ®Google Scholar
• American Psychiatric Association. 2000. Practice guideline for the treatment of patients with major depressive disorder (revision). American Psychiatric Association. Am J Psychiatry 157(4 Suppl):1–45.
   Web of Science ®Google Scholar
• Anderson IM, Ferrier IN, Baldwin RC, Cowen PJ, Howard L, Lewis G, et al. 2008. Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines. J Psychopharmacol 22(4):343–396.
   PubMed Web of Science ®Google Scholar
• Anderson IM, Nutt DJ, Deakin JF. 2000. Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines. British Association for Psychopharmacology. J Psychopharmacol 14(1):3–20.
   PubMed Web of Science ®Google Scholar
• Andrews G. 2001. Should depression be managed as a chronic disease? Br Med J 322(7283):419–421.
   PubMedGoogle Scholar
• Angst J. 1986. The course of affective disorders. Psychopathology 19(Suppl 2):47–52.
   PubMedGoogle Scholar
• Angst J. 1999. Major depression in 1998: are we providing optimal therapy? J Clin Psychiatry 60(Suppl 6):5–9.
   PubMedGoogle Scholar
• Angst J, Felder W, Frey R, Stassen HH. 1978. The course of affective disorders. I. Change of diagnosis of monopolar, unipolar, and bipolar illness. Arch Psychiatr Nervenkr 226(1):57–64.
   PubMedGoogle Scholar
• Angst J, Gamma A, Bowden CL, Azorin JM, Perugi G, Vieta E, et al. 2013. Evidence-based definitions of bipolar-I and bipolar-II disorders among 5,635 patients with major depressive episodes in the Bridge Study: validity and comorbidity. Eur Arch Psychiatry Clin Neurosci 263(8):663–673.
   PubMed Web of Science ®Google Scholar
• Angst J, Sellaro R, Stassen HH, Gamma A. 2005. Diagnostic conversion from depression to bipolar disorders: results of a long-term prospective study of hospital admissions. J Affect Disord 84(2–3):149–157.
   PubMed Web of Science ®Google Scholar
• Baldessarini RJ, Faedda GL, Offidani E, Vazquez GH, Marangoni C, Serra G, et al. 2013. Antidepressant-associated mood-switching and transition from unipolar major depression to bipolar disorder: a review. J Affect Disord 148(1):129–135.
   PubMed Web of Science ®Google Scholar
• Bandelow B, Zohar J, Hollander E, Kasper S, Moller HJ, Zohar J, et al. 2008. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders – first revision. World J Biol Psychiatry 9(4):248–312.
   PubMed Web of Science ®Google Scholar
• Bauer M, Adli M, Ricken R, Severus E, Pilhatsch M. 2014. Role of lithium augmentation in the management of major depressive disorder. CNS Drugs 28(4):331–342.
   PubMed Web of Science ®Google Scholar
• Bauer M, Bschor T, Kunz D, Berghofer A, Strohle A, Müller-Oerlinghausen B. 2000. Double-blind, placebo-controlled trial of the use of lithium to augment antidepressant medication in continuation treatment of unipolar major depression. Am J Psychiatry 157(9):1429–1435.
   PubMed Web of Science ®Google Scholar
• Bauer M, Pfennig A, Severus E, Whybrow PC, Angst J, Moller HJ. 2013. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: update 2013 on the acute and continuation treatment of unipolar depressive disorders. World J Biol Psychiatry 14(5):334–385.
   PubMed Web of Science ®Google Scholar
• Bauer M, Priebe S, Berghofer A, Bschor T, Kiesslinger U, Whybrow PC. 2001. Subjective response to and tolerability of long-term supraphysiological doses of levothyroxine in refractory mood disorders. J Affect Disord 64(1):35–42.
   PubMed Web of Science ®Google Scholar
• Bauer M, Whybrow PC, Angst J, Versiani M, Moller HJ. 2002a. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and continuation treatment of major depressive disorder. World J Biol Psychiatry 3(1):5–43.
   PubMedGoogle Scholar
• Bauer M, Whybrow PC, Angst J, Versiani M, Moller HJ. 2002b. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 2: maintenance treatment of major depressive disorder and treatment of chronic depressive disorders and subthreshold depressions. World J Biol Psychiatry 3(2):69–86.
   PubMedGoogle Scholar
• Beaulieu S, Saury S, Sareen J, Tremblay J, Schutz CG, McIntyre RS, et al. 2012. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid substance use disorders. Ann Clin Psychiatry 24(1):38–55.
   PubMed Web of Science ®Google Scholar
• Bendz H, Schon S, Attman PO, Aurell M. 2010. Renal failure occurs in chronic lithium treatment but is uncommon. Kidney Int 77(3):219–224.
   PubMed Web of Science ®Google Scholar
• Berger M, Riedel M, Tomova N, Obermeier M, Dittmann S, Moeller H-J, et al. 2013. Do current screening recommendations allow for early detection of lithium-induced hyperparathyroidism in patients with bipolar disorder? Int J Bipolar Disord 1:7.
   PubMedGoogle Scholar
• Berk M, Sarris J, Coulson CE, Jacka FN. 2013. Lifestyle management of unipolar depression. Acta Psychiatr Scand Suppl (443):38–54.
   PubMedGoogle Scholar
• Berlim MT, Van den Eynde F, Tovar-Perdomo S, Daskalakis ZJ. 2014. Response, remission and drop-out rates following high-frequency repetitive transcranial magnetic stimulation (rTMS) for treating major depression: a systematic review and meta-analysis of randomized, double-blind and sham-controlled trials. Psychol Med 44(2):225–239.
   PubMed Web of Science ®Google Scholar
• Bocchetta A, Ardau R, Burrai C, Chillotti C, Quesada G, Del ZM. 1998. Suicidal behavior on and off lithium prophylaxis in a group of patients with prior suicide attempts. J Clin Psychopharmacol 18(5):384–389.
   PubMed Web of Science ®Google Scholar
• Bond DJ, Hadjipavlou G, Lam RW, McIntyre RS, Beaulieu S, Schaffer A, et al. 2012. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid attention-deficit/hyperactivity disorder. Ann Clin Psychiatry 24(1):23–37.
   PubMed Web of Science ®Google Scholar
• Boulenger JP, Loft H, Florea I. 2012. A randomized clinical study of Lu AA21004 in the prevention of relapse in patients with major depressive disorder. J Psychopharmacol 26(11):1408–1416.
   PubMed Web of Science ®Google Scholar
• Bowden CL. 2005. A different depression: clinical distinctions between bipolar and unipolar depression. J Affect Disord 84(2–3):117–125.
   PubMed Web of Science ®Google Scholar
• Brakemeier EL, Merkl A, Wilbertz G, Quante A, Regen F, Buhrsch N, et al. 2014. Cognitive-behavioral therapy as continuation treatment to sustain response after electroconvulsive therapy in depression: a randomized controlled trial. Biol Psychiatry 76(3):194–202.
   PubMed Web of Science ®Google Scholar
• Brent D, Emslie G, Clarke G, Wagner KD, Asarnow JR, Keller M, et al. 2008. Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial. J Am Med Assoc 299(8):901–913.
   PubMed Web of Science ®Google Scholar
• Bschor T. 2014. Lithium in the treatment of major depressive disorder. Drugs 74(8):855–862.
   PubMed Web of Science ®Google Scholar
• Bschor T, Berghofer A, Strohle A, Kunz D, Adli M, Müller-Oerlinghausen B, et al. 2002. How long should the lithium augmentation strategy be maintained? A 1-year follow-up of a placebo-controlled study in unipolar refractory major depression. J Clin Psychopharmacol 22(4):427–430.
   PubMed Web of Science ®Google Scholar
• Burgess S, Geddes J, Hawton K, Townsend E, Jamison K, Goodwin G. 2001. Lithium for maintenance treatment of mood disorders. Cochrane Database Syst Rev (3):CD003013.
   Google Scholar
• Cheung A, Kusumakar V, Kutcher S, Dubo E, Garland J, Weiss M, et al. 2008. Maintenance study for adolescent depression. J Child Adolesc Psychopharmacol 18(4):389–394.
   PubMed Web of Science ®Google Scholar
• Christensen H, Griffiths KM, Jorm AF. 2004. Delivering interventions for depression by using the internet: randomised controlled trial. Br Med J 328(7434):265.
   PubMedGoogle Scholar
• Cipriani A, Hawton K, Stockton S, Geddes JR. 2013. Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis. Br Med J 346:f3646.
   PubMed Web of Science ®Google Scholar
• Cipriani A, Smith K, Burgess S, Carney S, Goodwin G, Geddes J. 2006. Lithium versus antidepressants in the long-term treatment of unipolar affective disorder. Cochrane Database Syst Rev (4):CD003492.
   Google Scholar
• Consensus Development Panel. 1985. NIMH/NIH Consensus Development Conference statement. Mood disorders: pharmacologic prevention of recurrences. Consensus Development Panel. Am J Psychiatry 142(4):469–476.
   PubMedGoogle Scholar
• Coppen A. 2000. Lithium in unipolar depression and the prevention of suicide. J Clin Psychiatry 61(Suppl 9):52–56.
   PubMedGoogle Scholar
• Coppen A, Standish-Barry H, Bailey J, Houston G, Silcocks P, Hermon C. 1990. Long-term lithium and mortality. Lancet 335(8701):1347.
   PubMed Web of Science ®Google Scholar
• Cox GR, Fisher CA, De SS, Phelan M, Akinwale OP, Simmons MB, et al. 2012. Interventions for preventing relapse and recurrence of a depressive disorder in children and adolescents. Cochrane Database Syst Rev 11:CD007504.
   Google Scholar
• Cuijpers P, Geraedts AS, van OP, Andersson G, Markowitz JC, van SA. 2011. Interpersonal psychotherapy for depression: a meta-analysis. Am J Psychiatry 168(6):581–592.
   PubMed Web of Science ®Google Scholar
• Daban C, Martinez-Aran A, Cruz N, Vieta E. 2008. Safety and efficacy of Vagus Nerve Stimulation in treatment-resistant depression. A systematic review. J Affect Disord 110(1–2):1–15.
   PubMed Web of Science ®Google Scholar
• Datto CJ, Levy S, Miller DS, Katz IR. 2001. Impact of maintenance ECT on concentration and memory. J ECT 17(3):170–174.
   PubMed Web of Science ®Google Scholar
• Davis JM. 2006. Lithium maintenance of unipolar depression. In: Bauer M, Grof P, Müller-Oerlinghausen B, editors. London: Informa Healthcare. p 99–108.
   Google Scholar
• Davis JM, Janicak PG, Hogan DM. 1999. Mood stabilizers in the prevention of recurrent affective disorders: a meta-analysis. Acta Psychiatr Scand 100(6):406–417.
   PubMed Web of Science ®Google Scholar
• Dawson R, Lavori PW, Coryell WH, Endicott J, Keller MB. 1998. Maintenance strategies for unipolar depression: an observational study of levels of treatment and recurrence. J Affect Disord 49(1):31–44.
   PubMed Web of Science ®Google Scholar
• Dodd S, Malhi GS, Tiller J, Schweitzer I, Hickie I, Khoo JP, et al. 2011. A consensus statement for safety monitoring guidelines of treatments for major depressive disorder. Aust NZ J Psychiatry 45(9):712–725.
   PubMed Web of Science ®Google Scholar
• Dudek D, Siwek M, Zielinska D, Jaeschke R, Rybakowski J. 2013. Diagnostic conversions from major depressive disorder into bipolar disorder in an outpatient setting: results of a retrospective chart review. J Affect Disord 144(1–2):112–115.
   PubMed Web of Science ®Google Scholar
• Edwards JG, Anderson I. 1999. Systematic review and guide to selection of selective serotonin reuptake inhibitors. Drugs 57(4):507–533.
   PubMed Web of Science ®Google Scholar
• Ellis P. 2004. Australian and New Zealand clinical practice guidelines for the treatment of depression. Aust NZ J Psychiatry 38(6):389–407.
   PubMed Web of Science ®Google Scholar
• Emslie GJ, Kennard BD, Mayes TL, Nightingale-Teresi J, Carmody T, Hughes CW, et al. 2008. Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents. Am J Psychiatry 165(4):459–467.
   PubMed Web of Science ®Google Scholar
• Fitzgerald PB, Daskalakis ZJ. 2012. A practical guide to the use of repetitive transcranial magnetic stimulation in the treatment of depression. Brain Stimul 5(3):287–296.
   PubMed Web of Science ®Google Scholar
• Frank E, Kupfer DJ, Perel JM, Cornes C, Jarrett DB, Mallinger AG, et al. 1990. Three-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry 47(12):1093–1099.
   PubMed Web of Science ®Google Scholar
• Frank E, Prien RF, Jarrett RB, Keller MB, Kupfer DJ, Lavori PW, et al. 1991. Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Arch Gen Psychiatry 48(9):851–855.
   PubMed Web of Science ®Google Scholar
• Gao K, Kemp DE, Fein E, Wang Z, Fang Y, Ganocy SJ, et al. 2011. Number needed to treat to harm for discontinuation due to adverse events in the treatment of bipolar depression, major depressive disorder, and generalized anxiety disorder with atypical antipsychotics. J Clin Psychiatry 72(8):1063–1071.
   PubMed Web of Science ®Google Scholar
• Gaynes BN, Lloyd SW, Lux L, Gartlehner G, Hansen RA, Brode S, et al. 2014. Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and meta-analysis. J Clin Psychiatry 75(5):477–489.
   PubMed Web of Science ®Google Scholar
• Georgotas A, McCue RE, Cooper TB. 1989. A placebo-controlled comparison of nortriptyline and phenelzine in maintenance therapy of elderly depressed patients. Arch Gen Psychiatry 46(9):783–786.
   PubMed Web of Science ®Google Scholar
• Gilaberte I, Montejo AL, de la Gandara J, Perez-Sola V, Bernardo M, Massana J, et al. 2001. Fluoxetine in the prevention of depressive recurrences: a double-blind study. J Clin Psychopharmacol 21(4):417–424.
   PubMed Web of Science ®Google Scholar
• Goodwin GM, Emsley R, Rembry S, Rouillon F. 2009. Agomelatine prevents relapse in patients with major depressive disorder without evidence of a discontinuation syndrome: a 24-week randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 70(8):1128–1137.
   PubMed Web of Science ®Google Scholar
• Gorwood P, Weiller E, Lemming O, Katona C. 2007. Escitalopram prevents relapse in older patients with major depressive disorder. Am J Geriatr Psychiatry 15(7):581–593.
   PubMed Web of Science ®Google Scholar
• Greenhouse JB, Stangl D, Kupfer DJ, Prien RF. 1991. Methodologic issues in maintenance therapy clinical trials. Arch Gen Psychiatry 48(4):313–318.
   PubMed Web of Science ®Google Scholar
• Greil W, Ludwig-Mayerhofer W, Erazo N, Engel RR, Czernik A, Giedke H, et al. 1996. Comparative efficacy of lithium and amitriptyline in the maintenance treatment of recurrent unipolar depression: a randomised study. J Affect Disord 40(3):179–190.
   PubMed Web of Science ®Google Scholar
• Grof P. 1998. Has the effectiveness of lithium changed? Impact of the variety of lithium's effects. Neuropsychopharmacology 19(3):183–188.
   PubMed Web of Science ®Google Scholar
• Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Moller HJ, et al. 2009. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania. World J Biol Psychiatry 10(2):85–116.
   PubMed Web of Science ®Google Scholar
• Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Moller HJ, et al. 2010. The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression. World J Biol Psychiatry 11(2):81–109.
   PubMed Web of Science ®Google Scholar
• Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Moller HJ, et al. 2013. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder. World J Biol Psychiatry 14(3):154–219.
   PubMed Web of Science ®Google Scholar
• Guzzetta F, Tondo L, Centorrino F, Baldessarini RJ. 2007. Lithium treatment reduces suicide risk in recurrent major depressive disorder. J Clin Psychiatry 68(3):380–383.
   PubMed Web of Science ®Google Scholar
• Haddad PM. 2001. Antidepressant discontinuation syndromes. Drug Saf 24(3):183–197.
   PubMed Web of Science ®Google Scholar
• Härter M, Klesse C, Bermejo I, Bschor T, Gensichen J, Harfst T, et al. 2010. [Evidence-based therapy of depression: S3 guidelines on unipolar depression]. Nervenarzt 81(9):1049–1068.
   PubMed Web of Science ®Google Scholar
• Hegerl U, Allgaier AK, Henkel V, Mergl R. 2011. Can effects of antidepressants in patients with mild depression be considered as clinically significant? J Affect Disord 138(3);183–191.
   PubMed Web of Science ®Google Scholar
• Hochstrasser B, Isaksen PM, Koponen H, Lauritzen L, Mahnert FA, Rouillon F, et al. 2001. Prophylactic effect of citalopram in unipolar, recurrent depression: placebo-controlled study of maintenance therapy. Br J Psychiatry 178:304–310.
   PubMed Web of Science ®Google Scholar
• Judd LL. 1997. The clinical course of unipolar major depressive disorders. Arch Gen Psychiatry 54(11):989–991.
   PubMed Web of Science ®Google Scholar
• Judd LL, Akiskal HS. 2000. Delineating the longitudinal structure of depressive illness: beyond clinical subtypes and duration thresholds. Pharmacopsychiatry 33(1):3–7.
   PubMed Web of Science ®Google Scholar
• Judd LL, Akiskal HS, Maser JD, Zeller PJ, Endicott J, Coryell W, et al. 1998. A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders. Arch Gen Psychiatry 55(8):694–700.
   PubMed Web of Science ®Google Scholar
• Judd LL, Paulus MJ, Schettler PJ, Akiskal HS, Endicott J, Leon AC, et al. 2000. Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness? Am J Psychiatry 157(9):1501–1504.
   PubMed Web of Science ®Google Scholar
• Kane JM, Quitkin FM, Rifkin A, Ramos-Lorenzi JR, Nayak DD, Howard A. 1982. Lithium carbonate and imipramine in the prophylaxis of unipolar and bipolar II illness: a prospective, placebo-controlled comparison. Arch Gen Psychiatry 39(9):1065–1069.
   PubMed Web of Science ®Google Scholar
• Kasper S, Volz HP, Moller HJ, Dienel A, Kieser M. 2008. Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after recovery from an acute episode of moderate depression – a double-blind, randomized, placebo controlled long-term trial. Eur Neuropsychopharmacol 18(11):803–813.
   PubMed Web of Science ®Google Scholar
• Katon W, Rutter C, Ludman EJ, Von KM, Lin E, Simon G, et al. 2001. A randomized trial of relapse prevention of depression in primary care. Arch Gen Psychiatry 58(3):241–247.
   PubMed Web of Science ®Google Scholar
• Kelin K, Berk M, Spann M, Sagman D, Raskin J, Walker D, Perahia D. 2010. Duloxetine 60 mg/day for the prevention of depressive recurrences: post hoc analyses from a recurrence prevention study. Int J Clin Pract 64(6):719–726.
   PubMed Web of Science ®Google Scholar
• Keller MB, Lavori PW, Rice J, Coryell W, Hirschfeld RM. 1986. The persistent risk of chronicity in recurrent episodes of nonbipolar major depressive disorder: a prospective follow-up. Am J Psychiatry 143(1):24–28.
   PubMed Web of Science ®Google Scholar
• Keller MB, Trivedi MH, Thase ME, Shelton RC, Kornstein SG, Nemeroff CB, et al. 2007. The prevention of recurrent episodes of depression with venlafaxine for two years (PREVENT) study: outcomes from the acute and continuation phases. Biol Psychiatry 62(12):1371–1379.
   PubMed Web of Science ®Google Scholar
• Kellner CH, Knapp RG, Petrides G, Rummans TA, Husain MM, Rasmussen K, et al. 2006. Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE). Arch Gen Psychiatry 63(12):1337–1344.
   PubMed Web of Science ®Google Scholar
• Kennedy SH, Lam RW, Parikh SV, Patten SB, Ravindran AV. 2009a. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. Introduction. J Affect Disord 117(Suppl 1):S1–2.
   PubMedGoogle Scholar
• Kennedy SH, Milev R, Giacobbe P, Ramasubbu R, Lam RW, Parikh SV, et al. 2009b. Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults. IV. Neurostimulation therapies. J Affect Disord 117(Suppl 1):S44–53.
   Google Scholar
• Kiloh LG, Andrews G, Neilson M. 1988. The long-term outcome of depressive illness. Br J Psychiatry 153:752–757.
   PubMed Web of Science ®Google Scholar
• Kim HR, Delva NJ, Lawson JS. 1990. Prophylactic medication for unipolar depressive illness: the place of lithium carbonate in combination with antidepressant medication. Can J Psychiatry 35(2):107–114.
   PubMed Web of Science ®Google Scholar
• Klerman GL, Weissman MM. 1989. Increasing rates of depression. J Am Med Asoc 261(15):2229–2235.
   PubMed Web of Science ®Google Scholar
• Klysner R, Bent-Hansen J, Hansen HL, Lunde M, Pleidrup E, Poulsen DL, et al. 2002. Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo-controlled study of maintenance therapy. Br J Psychiatry 181:29–35.
   PubMed Web of Science ®Google Scholar
• Kocsis JH, Thase ME, Trivedi MH, Shelton RC, Kornstein SG, Nemeroff CB, et al. 2007. Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT Study. J Clin Psychiatry 68(7):1014–1023.
   PubMed Web of Science ®Google Scholar
• Kornstein SG, Bose A, Li D, Saikali KG, Gandhi C. 2006. Escitalopram maintenance treatment for prevention of recurrent depression: a randomized, placebo-controlled trial. J Clin Psychiatry 67(11):1767–1775.
   PubMed Web of Science ®Google Scholar
• Kovacs M, Devlin B, Pollock M, Richards C, Mukerji P. 1997. A controlled family history study of childhood-onset depressive disorder. Arch Gen Psychiatry 54(7):613–623.
   PubMed Web of Science ®Google Scholar
• Kupfer DJ. 1993. Management of recurrent depression. J Clin Psychiatry 54(Suppl):29–33.
   PubMedGoogle Scholar
• Kupfer DJ, Frank E, Perel JM. 1989. The advantage of early treatment intervention in recurrent depression. Arch Gen Psychiatry 46(9):771–775.
   PubMed Web of Science ®Google Scholar
• Kupfer DJ, Frank E, Perel JM, Cornes C, Mallinger AG, Thase ME, et al. 1992. Five-year outcome for maintenance therapies in recurrent depression. Arch Gen Psychiatry 49(10):769–773.
   PubMed Web of Science ®Google Scholar
• Lam RW, Kennedy SH, Grigoriadis S, McIntyre RS, Milev R, Ramasubbu R, et al. 2009. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy. J Affect Disord 117(Suppl 1):S26–S43.
   PubMed Web of Science ®Google Scholar
• Lauterbach E, Felber W, Müller-Oerlinghausen B, Ahrens B, Bronisch T, Meyer T, et al. 2008. Adjunctive lithium treatment in the prevention of suicidal behaviour in depressive disorders: a randomised, placebo-controlled, 1-year trial. Acta Psychiatr Scand 118(6):469–479.
   PubMed Web of Science ®Google Scholar
• Lejoyeux M, Ades J. 1997. Antidepressant discontinuation: a review of the literature. J Clin Psychiatry 58(Suppl 7):11–15.
   PubMed Web of Science ®Google Scholar
• Lepine JP, Caillard V, Bisserbe JC, Troy S, Hotton JM, Boyer P. 2004. A randomized, placebo-controlled trial of sertraline for prophylactic treatment of highly recurrent major depressive disorder. Am J Psychiatry 161(5):836–842.
   PubMed Web of Science ®Google Scholar
• Lepping P, Schonfeldt-Lecuona C, Sambhi RS, Lanka SV, Lane S, Whittington R, et al. 2014. A systematic review of the clinical relevance of repetitive transcranial magnetic stimulation. Acta Psychiatr Scand 130(5):326–341.
   PubMed Web of Science ®Google Scholar
• Licht RW. 2013. Is it possible to evaluate true prophylactic efficacy of antidepressants in severely ill patients with recurrent depression? Lessons from a placebo-controlled trial. The fifth trial of the Danish University Antidepressant Group (DUAG-5). J Affect Disord 148(2–3):286–290.
   PubMed Web of Science ®Google Scholar
• Liebowitz M, Lam RW, Lepola U, Datto C, Sweitzer D, Eriksson H. 2010. Efficacy and tolerability of extended release quetiapine fumarate monotherapy as maintenance treatment of major depressive disorder: a randomized, placebo-controlled trial. Depress Anxiety 27(10):964–976.
   PubMed Web of Science ®Google Scholar
• Livingstone C, Rampes H. 2006. Lithium: a review of its metabolic adverse effects. J Psychopharmacol 20(3):347–355.
   PubMed Web of Science ®Google Scholar
• Lynch D, Laws KR, McKenna PJ. 2010. Cognitive behavioural therapy for major psychiatric disorder: does it really work? A meta-analytical review of well-controlled trials. Psychol Med 40(1):9–24.
   PubMed Web of Science ®Google Scholar
• Malhi GS, Tanious M, Gershon S. 2011. The lithiumeter: a measured approach. Bipolar Disord 13(3):219–226.
   PubMed Web of Science ®Google Scholar
• Marraccini RL, Reynolds CF III, Houck PR, Miller MD, Frank E, Perel JM, et al. 1999. A double-blind, placebo-controlled assessment of nortriptyline's side-effects during 3-year maintenance treatment in elderly patients with recurrent major depression. Int J Geriatr Psychiatry 14(12):1014–1018.
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Alsuwaidan M, Goldstein BI, Taylor VH, Schaffer A, Beaulieu S, et al. 2012a. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid metabolic disorders. Ann Clin Psychiatry 24(1):69–81.
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Schaffer A, Beaulieu S. 2012b. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid conditions. Ann Clin Psychiatry 24(1):2–3.
   PubMed Web of Science ®Google Scholar
• McKnight RF, Adida M, Budge K, Stockton S, Goodwin GM, Geddes JR. 2012. Lithium toxicity profile: a systematic review and meta-analysis. Lancet 379(9817):721–728.
   PubMed Web of Science ®Google Scholar
• Miret M, Ayuso-Mateos JL, Sanchez-Moreno J, Vieta E. 2013. Depressive disorders and suicide: epidemiology, risk factors, and burden. Neurosci Biobehav Rev 37(10 Pt 1):2372–2374.
   PubMed Web of Science ®Google Scholar
• Mohr DC, Ho J, Duffecy J, Reifler D, Sokol L, Burns MN, et al. 2012. Effect of telephone-administered vs face-to-face cognitive behavioral therapy on adherence to therapy and depression outcomes among primary care patients: a randomized trial. J Am Med Assoc 307(21):2278–2285.
   Web of Science ®Google Scholar
• Montgomery SA. 1994. Long-term treatment of depression. Br J Psychiatry Suppl (26):31–36.
   PubMedGoogle Scholar
• Montgomery SA. 1999. New developments in the treatment of depression. J Clin Psychiatry 60(Suppl 14):10–15.
   PubMedGoogle Scholar
• Montgomery SA, Dunbar G. 1993. Paroxetine is better than placebo in relapse prevention and the prophylaxis of recurrent depression. Int Clin Psychopharmacol 8(3):189–195.
   PubMed Web of Science ®Google Scholar
• Montgomery SA, Entsuah R, Hackett D, Kunz NR, Rudolph RL. 2004. Venlafaxine versus placebo in the preventive treatment of recurrent major depression. J Clin Psychiatry 65(3):328–336.
   PubMed Web of Science ®Google Scholar
• Montgomery SA, Reimitz PE, Zivkov M. 1998. Mirtazapine versus amitriptyline in the long-term treatment of depression: a double-blind placebo-controlled study. Int Clin Psychopharmacol 13(2):63–73.
   PubMed Web of Science ®Google Scholar
• Mosolov SN, Kuzavkova MV, Uzbekov MG, Misionzhhnik EI, Ryzhov AM. 1997. [A comparative clinico-pharmacokinetic study of the use of equivalent daily doses of lithium carbonate and Contemnol]. Zh Nevrol Psikhiatr Im S S Korsakova 97(5):30–33.
   PubMedGoogle Scholar
• Mueller TI, Leon AC, Keller MB, Solomon DA, Endicott J, Coryell W, et al. 1999. Recurrence after recovery from major depressive disorder during 15 years of observational follow-up. Am J Psychiatry 156(7):1000–1006.
   PubMed Web of Science ®Google Scholar
• Müller-Oerlinghausen B. 1999. Evidence report: treatment of depression – newer pharmacotherapies. Agency for Health Care Policy and Research (AHCPR). Pharmacopsychiatry 32(6):230–231.
   PubMed Web of Science ®Google Scholar
• Müller-Oerlinghausen B, Ahrens B, Grof E, Grof P, Lenz G, Schou M, et al. 1992. The effect of long-term lithium treatment on the mortality of patients with manic-depressive and schizoaffective illness. Acta Psychiatr Scand 86(3):218–222.
   PubMed Web of Science ®Google Scholar
• Müller-Oerlinghausen B, Wolf T, Ahrens B, Schou M, Grof E, Grof P, et al. 1994. Mortality during initial and during later lithium treatment. A collaborative study by the International Group for the Study of Lithium-treated Patients. Acta Psychiatr Scand 90(4):295–297.
   PubMed Web of Science ®Google Scholar
• Nahas Z, Marangell LB, Husain MM, Rush AJ, Sackeim HA, Lisanby SH, et al. 2005. Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. J Clin Psychiatry 66(9):1097–1104.
   PubMed Web of Science ®Google Scholar
• Navarro V, Gasto C, Torres X, Masana G, Penades R, Guarch J, et al. 2008. Continuation/maintenance treatment with nortriptyline versus combined nortriptyline and ECT in late-life psychotic depression: a two-year randomized study. Am J Geriatr Psychiatry 16(6):498–505.
   PubMed Web of Science ®Google Scholar
• Nelson JC, Papakostas GI. 2009. Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials. Am J Psychiatry 166(9):980–991.
   PubMed Web of Science ®Google Scholar
• NICE guidelines [CG90] 2009. Depression in adults: the treatment and management of depression in adults [Anonymous].
   Google Scholar
• Nolen WA, Weisler RH. 2013. The association of the effect of lithium in the maintenance treatment of bipolar disorder with lithium plasma levels: a post hoc analysis of a double-blind study comparing switching to lithium or placebo in patients who responded to quetiapine (Trial 144). Bipolar Disord 15(1):100–109.
   PubMed Web of Science ®Google Scholar
• O’Reardon JP, Blumner KH, Peshek AD, Pradilla RR, Pimiento PC. 2005. Long-term maintenance therapy for major depressive disorder with rTMS. J Clin Psychiatry 66(12):1524–1528.
   PubMed Web of Science ®Google Scholar
• Odeberg H, Rodriguez-Silva B, Salander P, Martensson B. 2008. Individualized continuation electroconvulsive therapy and medication as a bridge to relapse prevention after an index course of electroconvulsive therapy in severe mood disorders: a naturalistic 3-year cohort study. J ECT 24(3):183–190.
   PubMed Web of Science ®Google Scholar
• Pacchiarotti I, Baldessarini RJ, Nolen W, Grunze H, Licht R, Post R, et al. 2013. The International Society for Bipolar Disorders (ISBD) Task-Force report on antidepressants use in bipolar disorders. Am J Psychiatry.
   Web of Science ®Google Scholar
• Parikh SV, Segal ZV, Grigoriadis S, Ravindran AV, Kennedy SH, Lam RW, et al. 2009. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. II. Psychotherapy alone or in combination with antidepressant medication. J Affect Disord 117(Suppl 1):S15–25.
   Google Scholar
• Patten SB, Kennedy SH, Lam RW, O’Donovan C, Filteau MJ, Parikh SV, et al. 2009. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. I. Classification, burden and principles of management. J Affect Disord 117(Suppl 1):S5–14.
   PubMed Web of Science ®Google Scholar
• Paykel ES. 2001. Continuation and maintenance therapy in depression. Br Med Bull 57:145–159.
   PubMed Web of Science ®Google Scholar
• Perahia DG, Maina G, Thase ME, Spann ME, Wang F, Walker DJ, et al. 2009. Duloxetine in the prevention of depressive recurrences: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 70(5):706–716.
   PubMed Web of Science ®Google Scholar
• Peretti S, Judge R, Hindmarch I. 2000. Safety and tolerability considerations: tricyclic antidepressants vs. selective serotonin reuptake inhibitors. Acta Psychiatr Scand Suppl 403:17–25.
   PubMedGoogle Scholar
• Petrides G, Tobias KG, Kellner CH, Rudorfer MV. 2011. Continuation and maintenance electroconvulsive therapy for mood disorders: review of the literature. Neuropsychobiology 64(3):129–140.
   PubMed Web of Science ®Google Scholar
• Piet J, Hougaard E. 2011. The effect of mindfulness-based cognitive therapy for prevention of relapse in recurrent major depressive disorder: a systematic review and meta-analysis. Clin Psychol Rev 31(6):1032–1040.
   PubMed Web of Science ®Google Scholar
• Placidi GF, Lenzi A, Lazzerini F, Cassano GB, Akiskal HS. 1986. The comparative efficacy and safety of carbamazepine versus lithium: a randomized, double-blind 3-year trial in 83 patients. J Clin Psychiatry 47(10):490–494.
   PubMed Web of Science ®Google Scholar
• Prien RF, Kupfer DJ, Mansky PA, Small JG, Tuason VB, Voss CB, et al. 1984. Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Report of the NIMH Collaborative Study Group comparing lithium carbonate, imipramine, and a lithium carbonate-imipramine combination. Arch Gen Psychiatry 41(11):1096–1104.
   PubMed Web of Science ®Google Scholar
• Ramasubbu R, Beaulieu S, Taylor VH, Schaffer A, McIntyre RS. 2012a. The CANMAT task force recommendations for the management of patients with mood disorders and comorbid medical conditions: diagnostic, assessment, and treatment principles. Ann Clin Psychiatry 24(1):82–90.
   PubMed Web of Science ®Google Scholar
• Ramasubbu R, Taylor VH, Samaan Z, Sockalingham S, Li M, Patten S, et al. 2012b. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and select comorbid medical conditions. Ann Clin Psychiatry 24(1):91–109.
   PubMed Web of Science ®Google Scholar
• Rami L, Bernardo M, Boget T, Ferrer J, Portella MJ, Gil-Verona JA, et al. 2004. Cognitive status of psychiatric patients under maintenance electroconvulsive therapy: a one-year longitudinal study. J Neuropsychiatry Clin Neurosci 16(4):465–471.
   PubMed Web of Science ®Google Scholar
• Rami-Gonzalez L, Salamero M, Boget T, Catalan R, Ferrer J, Bernardo M. 2003. Pattern of cognitive dysfunction in depressive patients during maintenance electroconvulsive therapy. Psychol Med 33(2):345–350.
   PubMed Web of Science ®Google Scholar
• Rapaport MH, Bose A, Zheng H. 2004. Escitalopram continuation treatment prevents relapse of depressive episodes. J Clin Psychiatry 65(1):44–49.
   PubMed Web of Science ®Google Scholar
• Ravindran AV, Lam RW, Filteau MJ, Lesperance F, Kennedy SH, Parikh SV, et al. 2009. Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults. V. Complementary and alternative medicine treatments. J Affect Disord 117(Suppl 1):S54–64.
   Google Scholar
• Reynolds CF III, Alexopoulos GS, Katz IR, Lebowitz BD. 2001. Chronic depression in the elderly: approaches for prevention. Drugs Aging 18(7):507–514.
   PubMed Web of Science ®Google Scholar
• Reynolds CF III, Dew MA, Pollock BG, Mulsant BH, Frank E, Miller MD, et al. 2006. Maintenance treatment of major depression in old age. New Engl J Med 354(11):1130–1138.
   PubMed Web of Science ®Google Scholar
• Reynolds CF III, Frank E, Perel JM, Imber SD, Cornes C, Miller MD, et al. 1999a. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized controlled trial in patients older than 59 years. J Am Med Assoc 281(1):39–45.
   Web of Science ®Google Scholar
• Reynolds CF III, Perel JM, Frank E, Cornes C, Miller MD, Houck PR, et al. 1999b. Three-year outcomes of maintenance nortriptyline treatment in late-life depression: a study of two fixed plasma levels. Am J Psychiatry 156(8):1177–1181.
   PubMed Web of Science ®Google Scholar
• Rosenbaum JF, Fava M, Hoog SL, Ascroft RC, Krebs WB. 1998. Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial. Biol Psychiatry 44(2):77–87.
   PubMed Web of Science ®Google Scholar
• Rosenbluth M, MacQueen G, McIntyre RS, Beaulieu S, Schaffer A. 2012. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid personality disorders. Ann Clin Psychiatry 24(1):56–68.
   PubMed Web of Science ®Google Scholar
• Rush AJ. 1999. Strategies and tactics in the management of maintenance treatment for depressed patients. J Clin Psychiatry 60(Suppl 14):21–26.
   PubMedGoogle Scholar
• Rush AJ, George MS, Sackeim HA, Marangell LB, Husain MM, Giller C, et al. 2000. Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study. Biol Psychiatry 47(4):276–286.
   PubMed Web of Science ®Google Scholar
• Sackeim HA, Haskett RF, Mulsant BH, Thase ME, Mann JJ, Pettinati HM, et al. 2001. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. J Am Med Assoc 285(10):1299–1307.
   Web of Science ®Google Scholar
• Schaffer A, McIntosh D, Goldstein BI, Rector NA, McIntyre RS, Beaulieu S, et al. 2012. The CANMAT task force recommendations for the management of patients with mood disorders and comorbid anxiety disorders. Ann Clin Psychiatry 24(1):6–22.
   PubMed Web of Science ®Google Scholar
• Schlaepfer TE, Bewernick BH, Kayser S, Madler B, Coenen VA. 2013. Rapid effects of deep brain stimulation for treatment-resistant major depression. Biol Psychiatry 73(12):1204–1212.
   PubMed Web of Science ®Google Scholar
• Schou M. 1989. Lithium prophylaxis: myths and realities. Am J Psychiatry 146(5):573–576.
   PubMed Web of Science ®Google Scholar
• Schou M. 1997. Forty years of lithium treatment. Arch Gen Psychiatry 54(1):9–13.
   PubMedGoogle Scholar
• Schou M. 2000. Suicidal behavior and prophylactic lithium treatment of major mood disorders: a review of reviews. Suicide Life Threat Behav 30(3):289–293.
   PubMed Web of Science ®Google Scholar
• Schule C, Zwanzger P, Baghai T, Mikhaiel P, Thoma H, Moller HJ, et al. 2003. Effects of antidepressant pharmacotherapy after repetitive transcranial magnetic stimulation in major depression: an open follow-up study. J Psychiatr Res 37(2):145–153.
   PubMed Web of Science ®Google Scholar
• Schwan S, Hallberg P. 2009. SSRIs, bone mineral density, and risk of fractures – a review. Eur Neuropsychopharmacol 19(10):683–692.
   PubMed Web of Science ®Google Scholar
• Scott J. 1988. Chronic depression. Br J Psychiatry 153:287–297.
   PubMed Web of Science ®Google Scholar
• Segal ZV, Bieling P, Young T, MacQueen G, Cooke R, Martin L, et al. 2010. Antidepressant monotherapy vs sequential pharmacotherapy and mindfulness-based cognitive therapy, or placebo, for relapse prophylaxis in recurrent depression. Arch Gen Psychiatry 67(12):1256–1264.
   PubMed Web of Science ®Google Scholar
• Severus E, Bauer M. 2013. Managing the risk of lithium-induced nephropathy in the long-term treatment of patients with recurrent affective disorders. BMC Med 11:34.
   PubMed Web of Science ®Google Scholar
• Severus WE, Kleindienst N, Seemuller F, Frangou S, Moller HJ, Greil W. 2008. What is the optimal serum lithium level in the long-term treatment of bipolar disorder – a review? Bipolar Disord 10(2):231–237.
   PubMed Web of Science ®Google Scholar
• Shimazu K, Shimodera S, Mino Y, Nishida A, Kamimura N, Sawada K, et al. 2011. Family psychoeducation for major depression: randomised controlled trial. Br J Psychiatry 198(5):385–390.
   PubMed Web of Science ®Google Scholar
• Shrivastava RK, Cohn C, Crowder J, Davidson J, Dunner D, Feighner J, et al. 1994. Long-term safety and clinical acceptability of venlafaxine and imipramine in outpatients with major depression. J Clin Psychopharmacol 14(5):322–329.
   PubMed Web of Science ®Google Scholar
• Simhandl C, Denk E, Thau K. 1993. The comparative efficacy of carbamazepine low and high serum level and lithium carbonate in the prophylaxis of affective disorders. J Affect Disord 28(4):221–231.
   PubMed Web of Science ®Google Scholar
• Smith DF. 2014. Exploratory meta-analysis on deep brain stimulation in treatment-resistant depression. Acta Neuropsychiatr 26(6):382–384.
   PubMed Web of Science ®Google Scholar
• Solomon DA, Bauer MS. 1993. Continuation and maintenance pharmacotherapy for unipolar and bipolar mood disorders. Psychiatr Clin North Am 16(3):515–540.
   PubMed Web of Science ®Google Scholar
• Solomon DA, Keller MB, Leon AC, Mueller TI, Shea MT, Warshaw M, et al. 1997. Recovery from major depression. A 10-year prospective follow-up across multiple episodes. Arch Gen Psychiatry 54(11):1001–1006.
   PubMed Web of Science ®Google Scholar
• Souza FG, Goodwin GM. 1991. Lithium treatment and prophylaxis in unipolar depression: a meta-analysis. Br J Psychiatry 158:666–675.
   PubMed Web of Science ®Google Scholar
• Spina E, Pisani F, Perucca E. 1996. Clinically significant pharmacokinetic drug interactions with carbamazepine. An update. Clin Pharmacokinet 31(3):198–214.
   PubMed Web of Science ®Google Scholar
• Stangier U, Hilling C, Heidenreich T, Risch AK, Barocka A, Schlosser R, et al. 2103. Maintenance cognitive-behavioral therapy and manualized psychoeducation in the treatment of recurrent depression: a multicenter prospective randomized controlled trial. Am J Psychiatry 170(6):624–632.
   Google Scholar
• Swoboda E, Conca A, Konig P, Waanders R, Hansen M. 2001. Maintenance electroconvulsive therapy in affective and schizoaffective disorder. Neuropsychobiology 43(1):23–28.
   PubMed Web of Science ®Google Scholar
• Taylor G, McNeill A, Girling A, Farley A, Lindson-Hawley N, Aveyard P. 2014. Change in mental health after smoking cessation: systematic review and meta-analysis. Br Med J 348:g1151.
   PubMed Web of Science ®Google Scholar
• Taylor MJ, Rudkin L, Bullemor-Day P, Lubin J, Chukwujekwu C, Hawton K. 2013. Strategies for managing sexual dysfunction induced by antidepressant medication. Cochrane Database Syst Rev 5:CD003382.
   Google Scholar
• Terra JL, Montgomery SA. 1998. Fluvoxamine prevents recurrence of depression: results of a long-term, double-blind, placebo-controlled study. Int Clin Psychopharmacol 13(2):55–62.
   PubMed Web of Science ®Google Scholar
• Thase ME. 1999. Long-term nature of depression. J Clin Psychiatry 60(Suppl 14):3–9.
   Google Scholar
• Thase ME, Gelenberg A, Kornstein SG, Kocsis JH, Trivedi MH, Ninan P, et al. 2011. Comparing venlafaxine extended release and fluoxetine for preventing the recurrence of major depression: results from the PREVENT study. J Psychiatr Res 45(3):412–420.
   PubMed Web of Science ®Google Scholar
• Thies-Flechtner K, Müller-Oerlinghausen B, Seibert W, Walther A, Greil W. 1996. Effect of prophylactic treatment on suicide risk in patients with major affective disorders. Data from a randomized prospective trial. Pharmacopsychiatry 29(3):103–107.
   PubMed Web of Science ®Google Scholar
• Tint A, Haddad PM, Anderson IM. 2008. The effect of rate of antidepressant tapering on the incidence of discontinuation symptoms: a randomised study. J Psychopharmacol 22(3):330–332.
   PubMed Web of Science ®Google Scholar
• Tondo L, Jamison KR, Baldessarini RJ. 1997. Effect of lithium maintenance on suicidal behavior in major mood disorders. Ann NY Acad Sci 836:339–351.
   PubMed Web of Science ®Google Scholar
• Valenti M, Pacchiarotti I, Bonnin CM, Rosa AR, Popovic D, Nivoli AM, et al. 2012. Risk factors for antidepressant-related switch to mania. J Clin Psychiatry 73(2):e271–276.
   Google Scholar
• van den Broek WW, Birkenhager TK, Mulder PG, Bruijn JA, Moleman P. 2006. Imipramine is effective in preventing relapse in electroconvulsive therapy-responsive depressed inpatients with prior pharmacotherapy treatment failure: a randomized, placebo-controlled trial. J Clin Psychiatry 67(2):263–268.
   PubMed Web of Science ®Google Scholar
• Vieta E, Colom F. 2011. Therapeutic options in treatment-resistant depression. Ann Med 43(7):512–530.
   PubMed Web of Science ®Google Scholar
• Vieta E, Cruz N. 2012. Head to head comparisons as an alternative to placebo-controlled trials. Eur Neuropsychopharmacol 22(11):800–303.
   PubMed Web of Science ®Google Scholar
• Vittengl JR, Clark LA, Dunn TW, Jarrett RB. 2007. Reducing relapse and recurrence in unipolar depression: a comparative meta-analysis of cognitive-behavioral therapy's effects. J Consult Clin Psychol 75(3):475–488.
   PubMed Web of Science ®Google Scholar
• Vothknecht S, Kho KH, van Schaick HW, Zwinderman AH, Middelkoop H, Blansjaar BA. 2003. Effects of maintenance electroconvulsive therapy on cognitive functions. J ECT 19(3):151–157.
   PubMed Web of Science ®Google Scholar
• Wells KB, Burnam MA, Rogers W, Hays R, Camp P. 1992. The course of depression in adult outpatients. Results from the Medical Outcomes Study. Arch Gen Psychiatry 49(10):788–794.
   PubMed Web of Science ®Google Scholar
• Wijkstra J, Nolen WA, Algra A, van Vliet IM, Kahn RS. 2000. Relapse prevention in major depressive disorder after successful ECT: a literature review and a naturalistic case series. Acta Psychiatr Scand 102(6):454–460.
   PubMed Web of Science ®Google Scholar
• Wilkinson P, Izmeth Z. 2012. Continuation and maintenance treatments for depression in older people. Cochrane Database Syst Rev 11:CD006727.
   Google Scholar
• Williams LJ, Henry MJ, Berk M, Dodd S, Jacka FN, Kotowicz MA, et al. 2008. Selective serotonin reuptake inhibitor use and bone mineral density in women with a history of depression. Int Clin Psychopharmacol 23(2):84–87.
   PubMed Web of Science ®Google Scholar
• Wilson KC, Mottram PG, Ashworth L, Abou-Saleh MT. 2003. Older community residents with depression: long-term treatment with sertraline. Randomised, double-blind, placebo-controlled study. Br J Psychiatry 182:492–497.
   PubMed Web of Science ®Google Scholar